Endo International (LTS:0Y5F) Current Accrued Expense : $443 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Endo International Current Accrued Expense?

Endo International's Current Accrued Expense for the quarter that ended in Dec. 2023 was $443 Mil.

Endo International's quarterly Current Accrued Expense declined from Jun. 2023 ($475 Mil) to Sep. 2023 ($472 Mil) and declined from Sep. 2023 ($472 Mil) to Dec. 2023 ($443 Mil).

Endo International's annual Current Accrued Expense declined from Dec. 2021 ($1,295 Mil) to Dec. 2022 ($578 Mil) and declined from Dec. 2022 ($578 Mil) to Dec. 2023 ($443 Mil).

Endo International Current Accrued Expense Historical Data

The historical data trend for Endo International's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Current Accrued Expense Chart

Endo International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

1,311.42

1,113.65

1,294.76

578.15

443.00

Endo International Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															578.15	507.18	475.50	471.72	443.00

Endo International Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Endo International Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Endo International's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo International (LTS:0Y5F) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4

Website

https://www.endo.com

Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (LTS:0Y5F) Headlines

No Headlines